Stocks Comparison
Charles River Laboratories International vs OmniAb: revenue, profit, margins and growth compared
Charles River Laboratories International brought in $4B of revenue in fiscal 2025, OmniAb $18.7M in fiscal 2025. Revenue changed by -0.9% at Charles River Laboratories International and -29.3% at OmniAb on the year before, so Charles River Laboratories International grew faster. Charles River Laboratories International kept -3.6% of its revenue as net profit, OmniAb -347.0%. Free cash flow was $518.5M at Charles River Laboratories International and -$37M at OmniAb.
Side by side, latest fiscal year
| CRL | OABI | |
|---|---|---|
| Fiscal year ended | FY2025 (December 27, 2025) | FY2025 (December 31, 2025) |
| Revenue | $4B | $18.7M |
| Revenue growth | -0.9% | -29.3% |
| Net income | -$144.3M | -$64.8M |
| Net margin | -3.6% | -347.0% |
| Free cash flow | $518.5M | -$37M |
| Free cash flow margin | 12.9% | -198.3% |
| Earnings per share (diluted) | -$2.91 | -$0.57 |
| Cash | $213.8M | $25.5M |
| Debt | $166K | n/a |
| Price to earnings | n/a | n/a |
| Market value | $14B | $670.2M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #72 of 523 · Health care | #413 of 523 · Health care |
Over the years
Questions about Charles River Laboratories International and OmniAb
Which is bigger by revenue, Charles River Laboratories International or OmniAb?
Charles River Laboratories International is bigger by revenue: $4B in fiscal 2025, against $18.7M for OmniAb in fiscal 2025.
Which keeps more of its revenue as profit, Charles River Laboratories International or OmniAb?
Charles River Laboratories International had a net margin of -3.6% in fiscal 2025; OmniAb had -347.0% in fiscal 2025.
Which grew revenue faster, Charles River Laboratories International or OmniAb?
In their latest fiscal years revenue changed by -0.9% at Charles River Laboratories International and -29.3% at OmniAb.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.